The cathepsin D (224C/T) polymorphism confers an increased risk to develop Alzheimer's disease in men.
暂无分享,去创建一个
[1] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[2] Nikolaos A Patsopoulos,et al. Claims of sex differences: an empirical assessment in genetic associations. , 2007, JAMA.
[3] K. Blennow,et al. The Cathepsin D rs17571 polymorphism: effects on CSF tau concentrations in Alzheimer disease , 2006, Human mutation.
[4] Kaj Blennow,et al. Towards compendia of negative genetic association studies: an example for Alzheimer disease , 2006, Human Genetics.
[5] A. Ariza,et al. Age at Onset: An Essential Variable for the Definition of Genetic Risk Factors for Sporadic Alzheimer's Disease , 2005, Annals of the New York Academy of Sciences.
[6] D. Y. Lee,et al. Lack of association of cathepsin D genetic polymorphism with Alzheimer's disease in Koreans. , 2005, Archives of gerontology and geriatrics.
[7] F. Panza,et al. The cathepsin D gene exon 2 (C224T) polymorphism and sporadic Alzheimer's disease in European populations. , 2005, The journals of gerontology. Series A, Biological sciences and medical sciences.
[8] E. Zocchi,et al. Autocrine and Paracrine Calcium Signaling by the CD38/NAD+/Cyclic ADP‐Ribose System , 2004, Annals of the New York Academy of Sciences.
[9] Zhenxin Zhang,et al. Association between Cathepsin D Polymorphism and Alzheimer’s Disease in a Chinese Han Population , 2004, Dementia and Geriatric Cognitive Disorders.
[10] W. Maier,et al. Putative association of polymorphism in the mannose 6-phosphate receptor gene with major depression and Alzheimer's disease , 2004, Psychiatric genetics.
[11] Christian Haass,et al. Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease , 2003, Science.
[12] M. Catani,et al. Cathepsin D Polymorphism in Italian Elderly Subjects with Sporadic Late-Onset Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.
[13] A. Pfeffer,et al. Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease , 2003, Neuroscience Letters.
[14] S. Sorbi,et al. Cathepsin D polymorphism in Italian sporadic and familial Alzheimer's disease , 2002, Neuroscience Letters.
[15] W. Maier,et al. Cathepsin D: screening for new polymorphisms using single-strand conformation polymorphism analysis. , 2002, International journal of molecular medicine.
[16] O. Combarros,et al. Lack of association between cathepsin D genetic polymorphism and Alzheimer disease in a Spanish sample. , 2002, American journal of medical genetics.
[17] L. Feuk,et al. SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. , 2001, Trends in genetics : TIG.
[18] L. Feuk,et al. Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease , 2001, European Journal of Human Genetics.
[19] H. Arai,et al. Cathepsin D polymorphism not associated with Alzheimer's disease in Japanese , 2001, Annals of neurology.
[20] R. Nitsch,et al. Non-replication of association between cathepsin D genotype and late onset Alzheimer disease. , 2001, American journal of medical genetics.
[21] M. McInnis,et al. No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease , 2001, Annals of neurology.
[22] M. McInnis,et al. Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies , 2000, Experimental Gerontology.
[23] S. Sevush,et al. The genetic association between Cathepsin D and Alzheimer's disease , 2000, Neuroscience Letters.
[24] S. DeKosky,et al. Genetic polymorphisms in the cathespin D and interleukin-6 genes and the risk of Alzheimer's disease , 2000, Neuroscience Letters.
[25] J. Pauls,et al. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease , 2000, Annals of neurology.
[26] S. McIlroy,et al. Cathepsin D gene exon 2 polymorphism and sporadic Alzheimer's disease , 1999, Neuroscience Letters.
[27] F. Jessen,et al. Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease , 1999, Neuroscience Letters.
[28] G. Lynch,et al. β-Amyloid increases cathepsin D levels in hippocampus , 1998, Neuroscience Letters.
[29] J. Haines,et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.
[30] J. Haines,et al. Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .
[31] U Seligsohn,et al. Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. , 1997, Clinical chemistry.
[32] Jinhe Li,et al. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: Evidence for early up-regulation of the endosomal-lysosomal system , 1995, Neuron.
[33] R. Nixon,et al. The Lysosomal System in Neurons , 1992 .
[34] M. Takeda,et al. Abnormal distribution of cathepsins in the brain of patients with Alzheimer's disease , 1991, Neuroscience Letters.
[35] E. Bird,et al. Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin , 1990, Brain Research.
[36] M. Mattei,et al. Cloning and sequencing of the 52K cathepsin D complementary deoxyribonucleic acid of MCF7 breast cancer cells and mapping on chromosome 11. , 1988, Molecular endocrinology.
[37] J. Kay,et al. Immunolocalization of cathepsin D in normal and neoplastic human tissues. , 1986, Journal of clinical pathology.
[38] Nick C Fox,et al. Letter abstract - Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's Disease , 2009 .
[39] D. Blacker,et al. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database , 2007, Nature Genetics.
[40] G. Lynch,et al. Beta-amyloid increases cathepsin D levels in hippocampus. , 1998, Neuroscience letters.
[41] I. Touitou,et al. Missense polymorphism (C/T224) in the human cathepsin D pro-fragment determined by polymerase chain reaction--single strand conformational polymorphism analysis and possible consequences in cancer cells. , 1994, European journal of cancer.
[42] M A Pericak-Vance,et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. , 1993, Neurology.
[43] R. Nixon,et al. The lysosomal system in neurons. Involvement at multiple stages of Alzheimer's disease pathogenesis. , 1992, Annals of the New York Academy of Sciences.
[44] R. Nixon,et al. Proteases and Protease Inhibitors in Alzheimer's Disease Pathogenesis. Proceedings of a conference. Bethesda, Maryland, December 16-18, 1991. , 1992, Annals of the New York Academy of Sciences.
[45] F. Ballard,et al. Lysosomes : their role in protein breakdown , 1987 .